SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-069240
Filing Date
2017-03-03
Accepted
2017-03-03 12:01:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d356146dsc13da.htm SC 13D/A 37793
  Complete submission text file 0001193125-17-069240.txt   39061
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89517 | Film No.: 17662221
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DR. SUITE 150 IRVING TX 75063
Business Address
Huff James Warren (Filed by) CIK: 0001662411 (see all company filings)

Type: SC 13D/A